The FDA 3486 form, a critical document disseminated by the Department of Health and Human Services and specific to the Food and Drug Administration, plays a pivotal role in ensuring the safety and efficacy of biological products. Integral to regulatory compliance, it facilitates the comprehensive reporting of any deviations encountered during the manufacturing, testing, storage, or distribution phases of biological product lifecycle. Through detailed sections that require the submission of establishment information, a thorough description of the biological product deviation (BPD), contributing factors or root causes, and follow-up actions, the form embodies a rigorous approach to maintaining product integrity and protecting public health. Each segment, deliberately constructed, calls for precise data, including the establishment’s identification number, the exact nature and timings of the BPD, and proactive measures taken in response, ensuring a systematic capture of potential quality concerns. Furthermore, the classification of the product as either blood or non-blood indicates the form’s applicability across a wide spectrum of biological entities, highlighting its significance in the continuous effort to uphold standards within the healthcare sector.
| Question | Answer |
|---|---|
| Form Name | Form FDA 3486 |
| Form Length | 8 pages |
| Fillable? | Yes |
| Fillable fields | 1 |
| Avg. time to fill out | 2 min 12 sec |
| Other names | form fda 3486, fda form 3486 instructions, fda 3486 form, frm 3486 |